Suppr超能文献

急性行为障碍的药理学管理:英国精神卫生服务机构进行的临床审计数据。

The pharmacological management of acute behavioural disturbance: Data from a clinical audit conducted in UK mental health services.

机构信息

1 Royal College of Psychiatrists, Centre for Quality Improvement, London, UK.

2 Institute of Mental Health, University of Nottingham, Nottingham, UK.

出版信息

J Psychopharmacol. 2019 Apr;33(4):472-481. doi: 10.1177/0269881118817170. Epub 2018 Dec 19.

Abstract

BACKGROUND

A quality improvement programme addressing prescribing practice for acutely disturbed behaviour was initiated by the Prescribing Observatory for Mental Health.

METHOD

This study analysed data from a baseline clinical audit conducted in inpatient mental health services in member trusts.

RESULTS

Fifty-eight mental health services submitted data on 2172 episodes of acutely disturbed behaviour. A benzodiazepine alone was administered in 60% of the 1091 episodes where oral medication only was used and in 39% of the 1081 episodes where parenteral medication (rapid tranquillisation) was used. Haloperidol was combined with lorazepam in 22% of rapid tranquillisation episodes and with promethazine in 3%. Physical violence towards others was strongly associated with receiving rapid tranquillisation in men (odds ratio 1.74, 1.25-2.44; p<0.001) as was actual or attempted self-harm in women (odds ratio 1.87, 1.19-2.94; p=0.007). Where physical violence towards others was exhibited, a benzodiazepine and antipsychotic was more likely to be prescribed than a benzodiazepine alone (odds ratio 1.39, 1.00-1.92; p=0.05). The data suggested that 25% of patients were at least 'extremely or continuously active' in the hour after rapid tranquillisation was administered.

CONCLUSION

The current management of acutely disturbed behaviour with parenteral medication may fail to achieve a calming effect in up to a quarter of episodes. The most common rapid tranquillisation combination used was lorazepam and haloperidol, for which the randomised controlled trial evidence is very limited. Rapid tranquillisation prescribing practice was not wholly consistent with the relevant National Institute for Health and Care Excellence guideline, which recommends intramuscular lorazepam on its own or intramuscular haloperidol combined with intramuscular promethazine. Clinical factors prompting the use of rapid tranquillisation rather than oral medication may differ between the genders.

摘要

背景

精神卫生处方观察站发起了一项旨在改善急性精神障碍患者处方行为的质量改进计划。

方法

本研究分析了成员信托机构住院精神卫生服务中进行的基线临床审计数据。

结果

58 个精神卫生服务机构提交了 2172 例急性精神障碍发作的数据。在仅使用口服药物的 1091 例发作中,单独使用苯二氮䓬类药物,在使用(快速镇静)注射药物的 1081 例发作中,也有 39%使用了苯二氮䓬类药物。在 22%的快速镇静发作中,氟哌啶醇与劳拉西泮合用,在 3%的快速镇静发作中与异丙嗪合用。男性中,与接受快速镇静治疗相关的他人身体暴力行为发生率较高(优势比 1.74,1.25-2.44;p<0.001),女性中与实际或企图自残行为相关(优势比 1.87,1.19-2.94;p=0.007)。在出现他人身体暴力行为的情况下,与单独使用苯二氮䓬类药物相比,更可能开具苯二氮䓬类药物和抗精神病药物(优势比 1.39,1.00-1.92;p=0.05)。数据表明,在快速镇静治疗后 1 小时内,至少有 25%的患者至少处于“极度或持续活跃”状态。

结论

目前使用注射药物治疗急性精神障碍的方法可能无法在四分之一的发作中达到镇静效果。最常用的快速镇静组合是劳拉西泮和氟哌啶醇,但关于这两种药物的随机对照试验证据非常有限。快速镇静处方实践不完全符合相关的国家卫生与保健卓越研究所指南,该指南建议单独使用肌肉内劳拉西泮或肌肉内氟哌啶醇联合肌肉内异丙嗪。促使使用快速镇静而不是口服药物的临床因素在两性之间可能不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/6431784/10382e565395/10.1177_0269881118817170-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验